These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29318576)

  • 1. Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.
    Saadah NH; van der Bom JG; Wiersum-Osselton JC; Richardson C; Middelburg RA; Politis C; Renaudier P; Robillard P; Schipperus MR
    Br J Haematol; 2018 Mar; 180(5):727-734. PubMed ID: 29318576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016.
    Politis C; Wiersum-Osselton J; Richardson C; Grouzi E; Sandid I; Marano G; Goto N; Condeço J; Boudjedir K; Asariotou M; Politi L; Land K
    Transfus Clin Biol; 2022 Aug; 29(3):243-249. PubMed ID: 35476961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
    Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
    Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries.
    Rogers MA; Rohde JM; Blumberg N
    Vox Sang; 2016 Apr; 110(3):266-77. PubMed ID: 26689441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.
    Saadah NH; van Hout FMA; Schipperus MR; le Cessie S; Middelburg RA; Wiersum-Osselton JC; van der Bom JG
    Transfusion; 2017 Sep; 57(9):2104-2114. PubMed ID: 28766723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute blood transfusion reactions in a tertiary care hospital in Pakistan - an initiative towards haemovigilance.
    Borhany M; Anwar N; Tariq H; Fatima N; Arshad A; Naseer I; Shamsi T
    Transfus Med; 2019 Aug; 29(4):275-278. PubMed ID: 29845667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
    van Hout FMA; van der Meer PF; Wiersum-Osselton JC; Middelburg RA; Schipperus MR; van der Bom JG; Kerkhoffs JL
    Transfusion; 2018 Apr; 58(4):1021-1027. PubMed ID: 29405304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
    Moncharmont P; Quittançon E; Barday G; Benamara A;
    Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight years with haemovigilance in Norway. What have we learnt?
    Steinsvåg CT; Espinosa A; Flesland Ø
    Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance.
    Wiersum-Osselton JC; Politis C; Richardson C; Goto N; Grouzi E; Marano G; Land KJ
    Vox Sang; 2021 Jul; 116(6):628-636. PubMed ID: 33278040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
    Oakley FD; Woods M; Arnold S; Young PP
    Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of haemovigilance and reports on transfusion reaction in blood component therapy].
    Grujić J; Gulan Z; Budakov Z
    Med Pregl; 2012; 65(1-2):50-3. PubMed ID: 22452240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of complication rates based on published haemovigilance data.
    Flesland O
    Intensive Care Med; 2007 Jun; 33 Suppl 1():S17-21. PubMed ID: 17676435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
    Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
    Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
    Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021).
    Lemssahli I; Benajiba M; Belmekki A
    Pan Afr Med J; 2024; 47():60. PubMed ID: 38646139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of complications after blood components' transfusions.
    Timler D; Klepaczka J; Kasielska-Trojan A; Bogusiak K
    Pol Przegl Chir; 2015 Apr; 87(4):166-73. PubMed ID: 26146115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.
    Vamvakas EC
    Transfusion; 2009 Dec; 49(12):2743-58. PubMed ID: 19682339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.